Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
3.240
-1.160 (-26.36%)
At close: Mar 11, 2026, 4:00 PM EDT
3.290
+0.050 (1.54%)
After-hours: Mar 11, 2026, 7:59 PM EDT
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $7.31 million as of March 11, 2026. Its market cap has decreased by -69.79% in one year.
Market Cap
7.31M
Enterprise Value
-2.66M
1-Year Change
-69.79%
Ranking
n/a
Category
Stock Price
$3.24
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $65.00M to $7.31M, a decrease of -88.75%. That is a compound annual growth rate of -22.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 4.80M | -53.40% |
| Dec 31, 2025 | 10.30M | -56.90% |
| Dec 31, 2024 | 23.90M | -41.28% |
| Dec 29, 2023 | 40.70M | -47.75% |
| Dec 30, 2022 | 77.90M | -69.81% |
| Dec 31, 2021 | 258.00M | -1.86% |
| Dec 31, 2020 | 262.90M | 1,596.13% |
| Dec 31, 2019 | 15.50M | -19.27% |
| Dec 31, 2018 | 19.20M | -40.74% |
| Dec 29, 2017 | 32.40M | -50.15% |
| Jul 12, 2017 | 65.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivos Therapeutics | 14.08M |
| Trinity Biotech | 12.25M |
| Sintx Technologies | 11.06M |
| Lifeward | 9.70M |
| Tenon Medical | 8.80M |
| Beyond Air | 8.68M |
| HeartSciences | 8.30M |
| Nexalin Technology | 8.07M |